• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Blog
  • News & Events
  • Videos
  • Resources
main-logo-small

Compliance Architects

Consulting Technology Outsourcing

  • About Us
    • Senior Staff
    • Why Us
    • Mission And Vision
    • Clients
    • Partners
    • Career Opportunities
  • Services
    • Inspection Readiness & Enforcement
      • FDA Inspection Readiness
      • Audits & Assessments
      • FDA Enforcement Response/Remediation
    • FDA Quality Consulting
      • Quality System & Compliance Turnarounds / Restructuring
      • Training / Coaching
      • Quality & Compliance Computer-Based Systems
      • External Supply Chain Compliance
      • Part 11 & Computer Systems Validation
      • Turnkey Quality Systems
    • Quality Assurance and Engineering
      • CRPN Quality Roadmap®
      • Quality Culture Assessment
      • Product Quality Consulting
      • Operational Efficiency/Compliance Effectiveness
      • Project/Program Management
    • Corporate Compliance and Litigation
      • Corporate Compliance Programs
      • Interactions With Department Of Justice And The Courts
    • FDA Regulatory Consultants
      • Product Development / Submissions / Commercialization
      • REMS (Risk Evaluation And Mitigation Strategies)
      • Mergers / Acquisitions / Licensing
    • Quality, Compliance, Regulatory & Operations’ Staffing
      • Staffing
      • Talent Management
      • Rapid Turnaround
  • Innovative Solutions
    • Writing for Compliance®
    • CRPN Quality Roadmap®
    • Quality Pulse®
    • IEEP
    • REMS
  • Success Stories
  • Industries
    • Biopharmaceuticals
    • Cannabis/CBD
    • Cell & Gene Therapies
    • Combination Products
    • Cosmetics
    • Dietary Supplements
    • Medical Devices and Diagnostics
    • Pharmaceuticals
  • Contact Us

Jack Garvey to Moderate Panel on Pharmaceutical Quality Metrics at October FDAnews Inspections Summit

FDA News LogoOn October 23, 2014, the annual FDAnews Inspections Summit will be the forum for an exciting, informative panel focused on the FDA’s upcoming Quality Metrics program. Moderating this important, joint FDA-industry panel will be Jack Garvey, Founder and Chief Executive Officer of Compliance Architects®. The following outlines the forum and the participants.

FDA’s Quality Metrics Program — What are the Latest Developments and How They May Impact Risk-Based Inspections

In 2015, the FDA expects to start collecting quality data it will use to determine inspectional frequency and rigor of drug and biologics makers. The data being considered could include number of lot release tests, out-of-specification results, and lots attempted, rejected, reworked, and reprocessed along with potentially other metrics as yet undetermined. In addition, by the end of this year, the International Society for Pharmaceutical Engineering (ISPE) intends to have initial results of their own quality metrics reporting pilot program. They will be sharing their findings with FDA on how manufacturers are coping with the collection and reporting process.

This panel of industry experts will explore the current state of the FDA’s quality metrics program, ISPE efforts and other programs under development within the industry. They will profile what activities have been performed to date, examining both the potential benefits and possible risks.

The panel is comprised of the following individuals:

Moderator:

John C. (Jack) Garvey, Founder & Chief Executive Officer, Compliance Architects LLC

Panelists:

  • Dr. Neil Stiber, Operations Research Analyst, Office of Strategic Programs, CDER, FDA
  • Dr. Patrick Brady, Deputy Vice President of Scientific and Regulatory Affairs, PhRMA
  • Kevin Roberson, Director, CGMP Quality Assurance, ABC Laboratories
  • Máiréad Goetz, Head of Compliance, Group Compliance and Audit, Group Quality Assurance, Novartis Pharmaceuticals
  • Denyse Baker, Senior Advisor, Scientific and Regulatory Affairs, PDA; former Quality Assurance Specialist, Office of New Drug Quality Assessment, CDER, FDA
  • Reem Malki, Vice President, Global Quality Operations, Mylan

Take the Pharmaceutical Metrics Survey!

In an effort to identify current industry readiness for and existing concerns about the FDA Quality Metrics Program, FDAnews, in cooperation with Compliance Architects®, is seeking pharmaceutical industry input in advance of the 2014 Inspections Summit. Specifically, FDAnews and Compliance Architects® have developed a broad-based survey to obtain data on industry’s state of readiness. We are NOW SEEKING YOUR HELP. Please follow the link below to access and respond to this important survey. Survey results will be shared with Inspections Summit attendees and published in subsequent FDAnews information offerings for broader industry awareness. To participate, click here to access and complete the survey: FDAnews Inspections Summit Metrics Survey

For further information on getting ready for FDA’s pharmaceutical quality metrics program, contact Jack Garvey, Compliance Architects® at  john.garvey@compliancearchitects.com or at 888-REG-XPRT.

Primary Sidebar

Sign Up To Our Newsletter

Related Compliance News

Susan (Sue) Soderholm joins Compliance Architects® as Managing Consultant

Due to business success and unparalleled growth, we are thrilled to announce the addition of a second executive in the same week to the Compliance

Randall “Randy” Lumia, SPHR, SHRM-SCP joins Compliance Architects® full-time as Vice President of Human Resources & Organizational Effectiveness

It gives us great pleasure to announce that Randy has joined us as a full-time Vice President of Human Resources & Organizational Effectiveness.  As many

Compliance Architects® is Gold Sponsor of FDLI Enforcement, Litigation & Compliance Conference

Compliance Architects® is proud to announce that it will be a Gold Sponsor of the upcoming FDLI Enforcement, Litigation & Compliance Conference to be held in Washington, DC on

Footer

Compliance Architects®

  • Contact Us
  • (888) 734-9778
  • info@compliancearchitects.com

Quick Links

  • About Us
    • Senior Staff
    • Why Us
    • Mission And Vision
    • Clients
    • Partners
    • Career Opportunities
  • Services
    • Inspection Readiness & Enforcement
      • FDA Inspection Readiness
      • Audits & Assessments
      • FDA Enforcement Response/Remediation
    • FDA Quality Consulting
      • Quality System & Compliance Turnarounds / Restructuring
      • Training / Coaching
      • Quality & Compliance Computer-Based Systems
      • External Supply Chain Compliance
      • Part 11 & Computer Systems Validation
      • Turnkey Quality Systems
    • Quality Assurance and Engineering
      • CRPN Quality Roadmap®
      • Quality Culture Assessment
      • Product Quality Consulting
      • Operational Efficiency/Compliance Effectiveness
      • Project/Program Management
    • Corporate Compliance and Litigation
      • Corporate Compliance Programs
      • Interactions With Department Of Justice And The Courts
    • FDA Regulatory Consultants
      • Product Development / Submissions / Commercialization
      • REMS (Risk Evaluation And Mitigation Strategies)
      • Mergers / Acquisitions / Licensing
    • Quality, Compliance, Regulatory & Operations’ Staffing
      • Staffing
      • Talent Management
      • Rapid Turnaround
  • Innovative Solutions
    • Writing for Compliance®
    • CRPN Quality Roadmap®
    • Quality Pulse®
    • IEEP
    • REMS
  • Success Stories
  • Industries
    • Biopharmaceuticals
    • Cannabis/CBD
    • Cell & Gene Therapies
    • Combination Products
    • Cosmetics
    • Dietary Supplements
    • Medical Devices and Diagnostics
    • Pharmaceuticals
  • Contact Us

Our Services

  • Inspection Readiness & Enforcement
  • FDA Quality Consulting – Systems and Training
  • Quality Assurance and Engineering
  • Corporate Compliance and Litigation Services
  • FDA Regulatory Consultants – Due Diligence
  • Quality, Compliance, Regulatory & Operations’ Staffing Services

Proprietary Solutions

  • Writing for Compliance®
  • Quality Pulse®
  • CRPN Quality Roadmap®

© 2009-2023 Compliance Architects Holdings LLC – used by permission. All copyrights, trademarks and other intellectual property are the property of Compliance Architects Holdings LLC and are used by permission.

  • Debarment Certification Statement
  • Privacy Policy
  • Terms of Use

Contact Us Today

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT